A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Status:
Withdrawn
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of dexmedetomidine in the
prevention of postoperative delirium in subjects undergoing heart valve surgery with or
without coronary artery bypass surgery (CABG) using cardiopulmonary bypass (CPB).
Phase:
Phase 3
Details
Lead Sponsor:
Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer